Insulet Q2 results pressure Tandem, DexCom (PODD:NASDAQ)
· seekingalpha.com
Insulet (PODD) stock drops as the company cuts 2026 revenue guidance; Other diabetes plays Tandem Diabetes (TNDM) and Dexcom (DXCM) also drop. Read more here.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...